Monday, May 7, 2012
Exciting News in CF Research
Today is an exciting day for us! Vertex Pharmaceuticals announced preliminary results for their Phase 2 study combining Kalydeco and VX-890. They are testing this combination on people who have the same mutation as Jayla and Dylan. Very promising results with hopes of a quick move towards approval. Check it out! Vertex results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment